台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    85.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.58%
  • 成交量
    558
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-富邦-斗六 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-斗六 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2000.00286.0086.00-2425-0.47%
2025/01/22082.8000.0083.1004370.00%
2025/01/15083.4000.0081.9004600.00%
2024/12/1700.00183.6083.40-1582-0.17%
2024/12/1300.00587.2087.20-5587-0.85%
2024/12/12594.2000.0092.6055800.86%
2024/12/1000.00194.0093.80-1559-0.18%
2024/12/06198.9000.0095.0015600.18%
2024/12/05199.50199.6099.6005520.00%
2024/10/2500.000.196.5094.80-0.1927-0.01%
2024/10/2300.001101.0099.80-11,012-0.10%
2024/10/1100.00192.0090.90-11,571-0.06%
2024/10/0800.00198.3098.00-11,594-0.06%
2024/10/07299.051100.5099.4011,6420.06%
2024/09/302103.502105.00100.0001,7060.00%
2024/09/2500.00198.5097.60-12,066-0.05%
2024/09/232100.501103.00100.0012,2430.04%
2024/09/202101.502103.00101.0002,2780.00%
2024/09/192103.0000.00102.5022,2880.09%
2024/09/132104.002105.00105.0002,3280.00%
2024/09/1200.001103.50104.00-12,369-0.04%
2024/09/111102.5000.00102.0012,4250.04%
2024/09/101103.501105.00103.0002,4750.00%
2024/09/092103.502105.00105.5002,4990.00%
2024/09/061106.002106.00105.50-12,551-0.04%
2024/09/051111.0000.00105.5012,5660.04%
2024/09/0400.0015107.00109.00-152,594-0.58%
2024/09/0200.001116.50116.50-12,691-0.04%
2024/08/302117.751118.50116.5012,7630.04%
2024/08/2900.001119.00118.00-12,821-0.04%
2024/08/281120.501121.50119.0002,8880.00%
2024/08/279120.722121.75122.0072,9580.24%
2024/08/266119.751120.50120.5052,9860.17%
2024/08/231114.001114.50115.0003,0100.00%
2024/08/222115.258116.19114.50-63,003-0.20%
2024/08/2115117.305117.30117.00102,9980.33%
2024/08/202117.002115.25116.0002,9730.00%
2024/08/191111.5000.00111.5012,9260.03%
2024/08/161111.502113.00113.00-12,933-0.03%
2024/08/151113.501114.50113.0002,9360.00%
2024/08/141112.0000.00112.0012,9560.03%
2024/08/131108.002.1109.69113.50-1.12,981-0.04%
2024/08/124113.882113.75112.0022,9620.07%
2024/08/091109.001109.50107.5002,9260.00%
2024/08/0700.001104.00108.50-12,906-0.03%
2024/08/0500.000.199.8099.50-0.12,8530.00%
2024/08/021119.001113.00110.5002,8180.00%
2024/08/012118.501119.00117.0012,8020.04%
2024/07/301118.001119.00116.5002,7790.00%
2024/07/291121.5000.00113.5012,7480.04%
2024/07/260.2126.022124.75126.00-1.82,692-0.07%
2024/07/233132.333133.00132.0002,6660.00%
2024/07/2218141.6418138.17136.0002,6470.00%
2024/07/199156.395164.00145.5042,5720.16%
2024/07/181157.001161.50161.5002,3020.00%
2024/07/1100.007144.50140.00-72,163-0.32%
2024/07/087146.001140.50146.0062,0830.29%
2024/07/0500.000.2137.00133.00-0.22,039-0.01%
2024/07/041.2130.0800.00135.501.22,0270.06%
2024/07/033135.832137.25133.0012,0080.05%
2024/07/023131.833137.00140.0001,9350.00%
2024/07/011124.004129.70139.50-31,729-0.18%
2024/06/283122.839122.39127.00-61,623-0.37%
2024/06/2700.001115.50115.50-11,436-0.07%
2024/06/24194.40295.3094.20-11,371-0.07%
2024/06/21194.6000.0093.7011,3510.07%
2024/06/20699.40396.7099.4031,3080.23%
2024/06/19495.35196.0094.2031,2790.23%
2024/06/181.393.64295.9096.10-0.81,242-0.06%
2024/06/17189.50190.4091.5001,1950.00%
2024/06/14185.70187.9087.7001,1530.00%
2024/06/131085.53386.5085.3071,1250.62%
2024/06/12482.65584.3883.40-11,069-0.09%
2024/06/11883.13286.2082.8061,0510.57%
2024/06/071286.001382.9583.00-11,017-0.10%
2024/06/06382.33981.1981.20-6969-0.62%
2024/06/05280.40381.7787.00-1907-0.11%
2024/06/04582.78483.4080.0018360.12%
2024/06/031185.121384.7185.00-2773-0.26%
2024/05/31381.77181.9082.4026900.29%
2024/05/16367.20366.2066.2004220.00%
2024/04/09066.7000.0065.9002720.00%
2024/03/1500.000.162.5061.40-0.1230-0.04%
2024/03/0600.000.163.2063.00-0.1226-0.04%
2024/03/0400.000.162.9862.50-0.1224-0.04%
2024/02/2700.000.263.1163.00-0.2231-0.09%
2024/02/230.163.5000.0061.900.12210.05%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音